[{"address1": "630 5th Avenue", "address2": "20th Floor", "city": "New York", "state": "NY", "zip": "10111", "country": "United States", "phone": "844 689 3939", "website": "https://www.anavex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher U. Missling M.B.A., M.S., Ph.D.", "age": 58, "title": "President, CEO, Secretary & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 856100, "exercisedValue": 373526, "unexercisedValue": 10940450}, {"maxAge": 1, "name": "Ms. Sandra  Boenisch CPA, CGA", "age": 43, "title": "Principal Financial Officer & Treasurer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 209527, "exercisedValue": 0, "unexercisedValue": 553580}, {"maxAge": 1, "name": "Clint  Tomlinson", "title": "VP of Corporate", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adebayo  Laniyonu Ph.D.", "title": "Senior Vice President of Nonclinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Edward R Hammond M.D., M.P.H., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kun  Jin Ph.D.", "title": "Head of Biostatistics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Terrie  Kellmeyer Ph.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juan Carlos  Lopez-Talavera M.D., Ph.D.", "title": "Senior VP & Head of Research and Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.06, "open": 11.2, "dayLow": 10.78, "dayHigh": 11.2009, "regularMarketPreviousClose": 11.06, "regularMarketOpen": 11.2, "regularMarketDayLow": 10.78, "regularMarketDayHigh": 11.2009, "payoutRatio": 0.0, "beta": 0.67, "forwardPE": -17.428572, "volume": 742201, "regularMarketVolume": 742201, "averageVolume": 885530, "averageVolume10days": 1012340, "averageDailyVolume10Day": 1012340, "bid": 7.95, "ask": 13.83, "bidSize": 2, "askSize": 2, "marketCap": 937875392, "fiftyTwoWeekLow": 4.93, "fiftyTwoWeekHigh": 14.441, "fiftyDayAverage": 8.779, "twoHundredDayAverage": 8.55765, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 671357504, "profitMargins": 0.0, "floatShares": 82526408, "sharesOutstanding": 85416704, "sharesShort": 25212383, "sharesShortPriorMonth": 24099499, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.2953, "heldPercentInsiders": 0.03333, "heldPercentInstitutions": 0.37672, "shortRatio": 28.32, "shortPercentOfFloat": 0.3054, "impliedSharesOutstanding": 85371904, "bookValue": 1.169, "priceToBook": 9.392643, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -47141000, "trailingEps": -0.56, "forwardEps": -0.63, "lastSplitFactor": "1:4", "lastSplitDate": 1444176000, "52WeekChange": 0.9691253, "SandP52WeekChange": 0.10611236, "quoteType": "EQUITY", "currentPrice": 10.98, "targetHighPrice": 46.0, "targetLowPrice": 15.0, "targetMeanPrice": 34.33333, "targetMedianPrice": 42.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 115771000, "totalCashPerShare": 1.356, "totalDebt": 0, "quickRatio": 6.699, "currentRatio": 6.739, "returnOnAssets": -0.25436002, "returnOnEquity": -0.40168998, "freeCashflow": -13688500, "operatingCashflow": -29814000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AVXL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1752882703, "regularMarketTime": 1752868800, "exchange": "NMS", "messageBoardId": "finmb_13580387", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -0.723335, "regularMarketPrice": 10.98, "shortName": "Anavex Life Sciences Corp.", "longName": "Anavex Life Sciences Corp.", "postMarketPrice": 10.9988, "postMarketChange": 0.018800735, "regularMarketChange": -0.0800009, "regularMarketDayRange": "10.78 - 11.2009", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 885530, "fiftyTwoWeekLowChange": 6.0499997, "fiftyTwoWeekLowChangePercent": 1.2271805, "fiftyTwoWeekRange": "4.93 - 14.441", "fiftyTwoWeekHighChange": -3.4610004, "fiftyTwoWeekHighChangePercent": -0.23966487, "fiftyTwoWeekChangePercent": 96.91253, "earningsTimestamp": 1747135801, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754483400, "earningsCallTimestampStart": 1747139400, "earningsCallTimestampEnd": 1747139400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.63, "epsCurrentYear": -0.56, "priceEpsCurrentYear": -19.607141, "fiftyDayAverageChange": 2.2009993, "fiftyDayAverageChangePercent": 0.25071183, "twoHundredDayAverageChange": 2.42235, "twoHundredDayAverageChangePercent": 0.28306252, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1154525400000, "postMarketChangePercent": 0.17122711, "displayName": "Anavex Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]